Variant report

Variant	nsv1024028
Chromosome Location	chr6:5057399-5081990
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:627)
CpG islands
(count:305)
Chromatin interactive
region (count:18)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:627 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:5080593-5081453	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:5057191-5057683	HepG2	liver:	n/a	n/a
3	ARID3A	chr6:5078568-5078756	K562	blood:	n/a	n/a
4	ARID3A	chr6:5061184-5061881	HepG2	liver:	n/a	chr6:5061336-5061352 chr6:5061337-5061353
5	ARID3A	chr6:5068153-5068988	HepG2	liver:	n/a	n/a
6	ARID3A	chr6:5058888-5060402	HepG2	liver:	n/a	n/a
7	ARID3A	chr6:5078549-5078855	HepG2	liver:	n/a	n/a
8	ATF1	chr6:5078579-5078864	K562	blood:	n/a	n/a
9	BATF	chr6:5070104-5070318	GM12878	blood:	n/a	n/a
10	BHLHE40	chr6:5059504-5060003	HepG2	liver:	n/a	n/a
11	BHLHE40	chr6:5061459-5061709	HepG2	liver:	n/a	n/a
12	BHLHE40	chr6:5063171-5063209	K562	blood:	n/a	n/a
13	BHLHE40	chr6:5061449-5061672	HepG2	liver:	n/a	n/a
14	BHLHE40	chr6:5061410-5061732	HepG2	liver:	n/a	n/a
15	BHLHE40	chr6:5068350-5068896	HepG2	liver:	n/a	chr6:5068537-5068553
16	BRCA1	chr6:5068421-5068853	HepG2	liver:	n/a	chr6:5068421-5068428
17	CEBPB	chr6:5061423-5061868	Hela-S3	cervix:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
18	CEBPB	chr6:5068311-5068963	HepG2	liver:	n/a	n/a
19	CEBPB	chr6:5079933-5080518	HepG2	liver:	n/a	chr6:5080107-5080118
20	CEBPB	chr6:5061440-5061771	A549	lung:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
21	CEBPB	chr6:5057424-5057733	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr6:5061371-5061803	MCF-7	breast:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
23	CEBPB	chr6:5068292-5068755	HepG2	liver:	n/a	n/a
24	CEBPB	chr6:5061517-5061804	MCF-7	breast:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
25	CEBPB	chr6:5061408-5062298	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629 chr6:5062158-5062169
26	CEBPB	chr6:5057370-5057690	K562	blood:	n/a	n/a
27	CEBPB	chr6:5066870-5067148	A549	lung:	n/a	n/a
28	CEBPB	chr6:5061442-5061749	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
29	CEBPB	chr6:5068413-5068896	HepG2	liver:	n/a	n/a
30	CEBPB	chr6:5062025-5062220	K562	blood:	n/a	chr6:5062158-5062169
31	CEBPB	chr6:5059610-5060062	HepG2	liver:	n/a	n/a
32	CEBPB	chr6:5079974-5080258	K562	blood:	n/a	chr6:5080107-5080118
33	CEBPB	chr6:5079962-5080224	IMR90	lung:	n/a	chr6:5080107-5080118
34	CEBPB	chr6:5061422-5061903	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
35	CEBPB	chr6:5066825-5067162	HepG2	liver:	n/a	n/a
36	CEBPB	chr6:5061479-5061817	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
37	CEBPB	chr6:5078662-5078742	K562	blood:	n/a	n/a
38	CEBPB	chr6:5074315-5074563	HepG2	liver:	n/a	n/a
39	CEBPB	chr6:5061436-5061774	IMR90	lung:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
40	CEBPD	chr6:5059683-5060019	HepG2	liver:	n/a	n/a
41	CEBPD	chr6:5061440-5061760	HepG2	liver:	n/a	n/a
42	CEBPD	chr6:5068332-5068958	HepG2	liver:	n/a	n/a
43	CHD2	chr6:5081599-5081749	HepG2	liver:	n/a	n/a
44	CHD2	chr6:5068338-5068924	HepG2	liver:	n/a	n/a
45	CHD2	chr6:5059666-5060055	HepG2	liver:	n/a	n/a
46	CHD2	chr6:5057387-5057691	H1-hESC	embryonic stem cell:	n/a	n/a
47	CREB1	chr6:5068134-5069127	HepG2	liver:	n/a	chr6:5068752-5068765
48	CREB1	chr6:5068113-5069122	HepG2	liver:	n/a	chr6:5068752-5068765
49	CREB1	chr6:5059333-5060105	HepG2	liver:	n/a	n/a
50	CTCF	chr6:5057420-5057570	HCT-116	colon:	n/a	chr6:5057522-5057540

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:5068684-5068734	HRCEpiC	kidney:	n/a
2	chr6:5066984-5067034	AG04450	lung:	fetal
3	chr6:5066984-5067034	GM19239	blood:	n/a
4	chr6:5067092-5067142	AG09309	skin:	n/a
5	chr6:5066994-5067044	HEEpiC	esophagus:	n/a
6	chr6:5067092-5067142	U87	brain:	n/a
7	chr6:5066994-5067044	HRPEpiC	eye:	n/a
8	chr6:5067127-5067177	IMR90	lung:	fetal
9	chr6:5067127-5067177	HCT-116	colon:	n/a
10	chr6:5066994-5067044	NH-A	brain:	n/a
11	chr6:5067092-5067142	ovcar-3	ovarian:	n/a
12	chr6:5067127-5067177	HRCEpiC	kidney:	n/a
13	chr6:5066984-5067034	T-47D	breast:	n/a
14	chr6:5066994-5067044	CMK	blood:	n/a
15	chr6:5067127-5067177	GM19239	blood:	n/a
16	chr6:5068684-5068734	HUVEC	blood vessel:	n/a
17	chr6:5068684-5068734	HPAEpiC	pulmonary alveolar:	n/a
18	chr6:5066994-5067044	Hela-S3	cervix:	n/a
19	chr6:5068684-5068734	SK-N-SH	brain:	n/a
20	chr6:5067127-5067177	T-47D	breast:	n/a
21	chr6:5068684-5068734	H1-hESC	embryonic stem cell:	embryo
22	chr6:5067127-5067177	NHBE	bronchial:	n/a
23	chr6:5067092-5067142	HRE	kidney:	n/a
24	chr6:5066984-5067034	AG04449	skin:	fetal
25	chr6:5067127-5067177	HEK293	kidney:	embryo
26	chr6:5066984-5067034	H1-hESC	embryonic stem cell:	embryo
27	chr6:5067092-5067142	AG09319	gingival:	n/a
28	chr6:5067127-5067177	HL-60	blood:	n/a
29	chr6:5067127-5067177	ECC-1	luminal epithelium:	n/a
30	chr6:5066984-5067034	HUVEC	blood vessel:	n/a
31	chr6:5066984-5067034	MCF-7	breast:	n/a
32	chr6:5067127-5067177	GM12892	blood:	n/a
33	chr6:5067127-5067177	Hepatocyte	liver:	n/a
34	chr6:5066994-5067044	HCF	heart:	n/a
35	chr6:5068684-5068734	SKMC	muscle:	n/a
36	chr6:5066994-5067044	NT2-D1	testis:	n/a
37	chr6:5068684-5068734	HNPCEpiC	eye:	n/a
38	chr6:5067127-5067177	HNPCEpiC	eye:	n/a
39	chr6:5066984-5067034	IMR90	lung:	fetal
40	chr6:5068684-5068734	HRE	kidney:	n/a
41	chr6:5067127-5067177	ovcar-3	ovarian:	n/a
42	chr6:5067092-5067142	AoSMC	blood vessel:	n/a
43	chr6:5066984-5067034	HAEpiC	amniotic membrane:	n/a
44	chr6:5066994-5067044	T-47D	breast:	n/a
45	chr6:5066984-5067034	PFSK-1	brain:	n/a
46	chr6:5066994-5067044	BJ	skin:	n/a
47	chr6:5067092-5067142	SK-N-SH	brain:	n/a
48	chr6:5066984-5067034	ECC-1	luminal epithelium:	n/a
49	chr6:5067127-5067177	BJ	skin:	n/a
50	chr6:5067127-5067177	HMEC	breast:	n/a

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:5067584..5069589-chr6:5073200..5075622,2	MCF-7	breast:
2	chr6:5030674..5031313-chr6:5057093..5058040,2	K562	blood:
3	chr6:5056866..5057674-chr6:5135884..5136820,3	MCF-7	breast:
4	chr6:5063657..5065685-chr6:5065825..5068724,2	K562	blood:
5	chr6:5077831..5080462-chr6:5082551..5084098,2	K562	blood:
6	chr6:5078527..5079328-chr6:5115126..5116009,5	MCF-7	breast:
7	chr6:5079080..5082683-chr6:5086665..5090602,4	K562	blood:
8	chr6:5067420..5070838-chr6:5082550..5086486,3	MCF-7	breast:
9	chr6:5080171..5082939-chr6:5089292..5092079,2	MCF-7	breast:
10	chr6:5081137..5084088-chr6:5116635..5118182,2	MCF-7	breast:
11	chr6:5062947..5065809-chr6:5065825..5069416,3	K562	blood:
12	chr6:5056626..5057929-chr6:5115101..5116066,9	MCF-7	breast:
13	chr6:5072255..5076149-chr6:5080723..5083422,4	K562	blood:
14	chr6:5067584..5069589-chr6:5073200..5075622,2	MCF-7	breast:
15	chr6:5056624..5057532-chr6:5398465..5398983,2	K562	blood:
16	chr6:5079785..5081381-chr6:5089374..5091355,2	MCF-7	breast:
17	chr6:5057040..5058030-chr6:5115128..5116001,3	MCF-7	breast:
18	chr6:5072255..5076149-chr6:5080723..5083422,4	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LYRM4-2	chr6:5066029-5067216	NONHSAT107511
2	lnc-PPP1R3G-1	chr6:5072827-5072968	ENSG00000251561

No data

Variant related genes	Relation type
PPP1R3G	TF binding region
ENSG00000220685	TF binding region
ENSG00000271978	TF binding region
PPP1R3G	CpG island
ENSG00000220685	CpG island
ENSG00000271978	CpG island
ENSG00000219607	chromatin interactions
ENSG00000220685	chromatin interactions
ARPC5	miRNA target sites

Extended variants
information (count: 996 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:996 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7738402	chr6:5057399-5057400	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs142841055	chr6:5057420-5057421	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs192232086	chr6:5057424-5057425	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs180990468	chr6:5057425-5057426	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs571304193	chr6:5057468-5057469	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs538439282	chr6:5057486-5057487	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs560313684	chr6:5057511-5057512	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs571988123	chr6:5057515-5057516	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs536164608	chr6:5057532-5057533	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs554501097	chr6:5057544-5057545	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs200155991	chr6:5057567-5057568	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs145787807	chr6:5057581-5057582	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs374083693	chr6:5057589-5057590	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs543498602	chr6:5057619-5057620	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs17139296	chr6:5057629-5057630	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs556486597	chr6:5057656-5057657	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs577298621	chr6:5057676-5057677	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs185069490	chr6:5057686-5057687	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs560008063	chr6:5057703-5057704	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs370522518	chr6:5057723-5057724	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs530380653	chr6:5057758-5057759	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs552719696	chr6:5057773-5057774	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs373784254	chr6:5057776-5057777	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs576382208	chr6:5057781-5057782	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs138687882	chr6:5057796-5057797	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs190270953	chr6:5057817-5057818	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs28566783	chr6:5057821-5057822	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs141564546	chr6:5057822-5057823	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs538373951	chr6:5057823-5057824	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs547163273	chr6:5057824-5057825	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs111504867	chr6:5057829-5057830	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs554844552	chr6:5057845-5057846	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs568631168	chr6:5057863-5057864	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs576299500	chr6:5057864-5057865	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs537437156	chr6:5057880-5057881	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs534260376	chr6:5057895-5057896	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs139354596	chr6:5057904-5057905	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs570133760	chr6:5057925-5057926	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs149616763	chr6:5057936-5057937	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs146077582	chr6:5057953-5057954	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs553561286	chr6:5057958-5057959	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs565200060	chr6:5057959-5057960	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs575091302	chr6:5057987-5057988	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs555846547	chr6:5057998-5057999	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs562596231	chr6:5057999-5058000	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs542491168	chr6:5058001-5058002	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs79712636	chr6:5058008-5058009	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs76623652	chr6:5058009-5058010	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs2764119	chr6:5058044-5058045	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs140088594	chr6:5058065-5058066	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21364760	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
dysmorphism	22105932	CNVD
psychomotor delay	22105932	CNVD
Ovarian cancer	19193619	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:93 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:5054800-5058600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr6:5054800-5059800	Weak transcription	Fetal Kidney	kidney
3	chr6:5055200-5061400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr6:5057200-5057800	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr6:5057400-5057600	Enhancers	Fetal Intestine Small	intestine
6	chr6:5057400-5057600	Enhancers	GM12878-XiMat	blood
7	chr6:5057400-5058000	Enhancers	Fetal Muscle Trunk	muscle
8	chr6:5057600-5058200	Weak transcription	Fetal Intestine Small	intestine
9	chr6:5057600-5058200	Enhancers	Placenta	Placenta
10	chr6:5057600-5058600	Weak transcription	GM12878-XiMat	blood
11	chr6:5057600-5059200	Enhancers	HepG2	liver
12	chr6:5058200-5062000	Enhancers	Fetal Intestine Small	intestine
13	chr6:5058400-5058600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr6:5058400-5058600	Bivalent Enhancer	K562	blood
15	chr6:5058400-5058800	Enhancers	Primary hematopoietic stem cells short term culture	blood
16	chr6:5058600-5058800	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr6:5058600-5058800	Enhancers	GM12878-XiMat	blood
18	chr6:5058600-5059000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr6:5058600-5060400	Enhancers	Rectal Mucosa Donor 31	rectum
20	chr6:5058600-5060600	Enhancers	Fetal Intestine Large	intestine
21	chr6:5058600-5063000	Enhancers	Liver	Liver
22	chr6:5058800-5064000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr6:5059200-5059400	Enhancers	Rectal Mucosa Donor 29	rectum
24	chr6:5059200-5059800	Flanking Active TSS	HepG2	liver
25	chr6:5059800-5060000	Enhancers	Fetal Kidney	kidney
26	chr6:5059800-5064400	Enhancers	HepG2	liver
27	chr6:5060000-5060200	Enhancers	Rectal Mucosa Donor 29	rectum
28	chr6:5060600-5061200	Weak transcription	Fetal Intestine Large	intestine
29	chr6:5061200-5061400	Enhancers	Fetal Intestine Large	intestine
30	chr6:5061400-5062000	Enhancers	Adipose Nuclei	Adipose
31	chr6:5061400-5062200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr6:5062000-5067000	Weak transcription	Fetal Intestine Small	intestine
33	chr6:5063000-5067600	Weak transcription	Liver	Liver
34	chr6:5063400-5063800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr6:5063800-5064200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr6:5064000-5064200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr6:5064200-5067000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr6:5064400-5067400	Weak transcription	HepG2	liver
39	chr6:5065400-5067000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
40	chr6:5067000-5067200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr6:5067000-5067400	ZNF genes & repeats	Fetal Intestine Small	intestine
42	chr6:5067200-5067800	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr6:5067200-5068600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
44	chr6:5067400-5067800	ZNF genes & repeats	Brain Hippocampus Middle	brain
45	chr6:5067400-5068200	Enhancers	HepG2	liver
46	chr6:5067400-5074000	Weak transcription	Ovary	ovary
47	chr6:5067600-5068800	Enhancers	Liver	Liver
48	chr6:5067800-5071200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr6:5068000-5068600	Weak transcription	Fetal Intestine Small	intestine
50	chr6:5068200-5068800	Enhancers	Fetal Intestine Large	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links